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Increasing age is the greatest known risk factor for the sporadic
late-onset forms of neurodegenerative disorders such as Alz-
heimer’s disease (AD). One of the brain regions most severely
affected in AD is the hippocampus, a privileged structure that
contains adult neural stem cells (NSCs) with neurogenic capacity.
Hippocampal neurogenesis decreases during aging and the de-
crease is exacerbated in AD, but the mechanistic causes underlying
this progressive decline remain largely unexplored. We here in-
vestigated the effect of age on NSCs and neurogenesis by analyzing
the senescence accelerated mouse prone 8 (SAMP8) strain, a non-
transgenic short-lived strain that spontaneously develops a patholog-
ical profile similar to that of AD and that has been employed as a
model system to study the transition from healthy aging to neuro-
degeneration. We show that SAMP8 mice display an accelerated loss
of the NSC pool that coincides with an aberrant rise in BMP6 protein,
enhanced canonical BMP signaling, and increased astroglial differen-
tiation. In vitro assays demonstrate that BMP6 severely impairs NSC
expansion and promotes NSC differentiation into postmitotic astro-
cytes. Blocking the dysregulation of the BMP pathway and its proglio-
genic effect in vivo by intracranial delivery of the antagonist Noggin
restores hippocampal NSC numbers, neurogenesis, and behavior in
SAMP8 mice. Thus, manipulating the local microenvironment of the
NSC pool counteracts hippocampal dysfunction in pathological aging.
Our results shed light on interventions that may allow taking advan-
tage of the brain’s natural plastic capacity to enhance cognitive
function in late adulthood and in chronic neurodegenerative dis-
eases such as AD.
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Decades of research have firmly established that new neuronsare produced in the postnatal and adult hippocampus of most
mammals, including humans, due to the existence of a stem cell
reservoir that confers regenerative capacity to this brain area essential
in forming memories (1, 2). Despite the long-lasting plastic potential
of the hippocampus, defects in hippocampal neurogenesis emerge
during aging (3–6) and are exacerbated in pathological conditions
such as Alzheimer’s disease (AD) (7–9). Previous studies indicated
that the newly generated cells in aged mice develop at a slower
pace (6), have a reduced survival (10, 11), and differentiate less
into neurons and more into astrocytes (10–13), but why this de-
fective fate choice occurs and how we might manipulate stem cells
or their niche to effectively counteract hippocampal dysfunction
upon healthy and pathological aging remains largely unknown.
The neurogenic process involves several sequential steps.
First, quiescent neural stem cells (NSCs) with radial morphology
located in the subgranular zone (SGZ) of the dentate gyrus
(DG) are activated and enter the cell cycle; next, the NSCs
asymmetrically divide and produce nonradial (NR) proliferative
progenitors that generate the new neurons. Finally, the young
neurons mature and integrate into preexisting networks. Extra-
cellular short-range niche signals regulate neurogenesis at all
these different stages (14–16) and alterations in the niche
microenvironment may be linked to the age-related neurogenic
decline (17). A relevant family of secreted factors whose function
in the aged SGZ remains poorly defined is the bone morpho-
genetic protein (BMP) family (18). The expression of several
BMPs is dysregulated in the hippocampus of old mice, in
transgenic mouse models of familial AD, and in the brains of
patients with early and severe AD compared with nondemented
controls (19–24), pointing to a causative role of BMP signaling in
the neurogenic defects found during aging and in AD.
We here analyze the causes underlying the decline in adult
NSCs and neurogenesis during pathological aging, taking ad-
vantage of the senescence-accelerated mouse strain SAMP8.
This nontransgenic short-lived strain precociously and pro-
gressively develops learning and memory deficits and a multi-
systemic aging phenotype (25–27). SAMP8 also exhibits
increased amyloid precursor protein (APP) and amyloid β (Aβ)
levels, oxidative stress, tau phosphorylation, astrogliosis, and
many of the biochemical findings of AD starting at the age of 6
mo (28–30). Due to the spontaneous onset of pathology similar
to that of human disease, SAMP8 is considered a good animal
model for research into the transition from healthy aging to the
onset phase of sporadic AD (28–31). SAMP8 is evaluated in
reference to SAMR1, a genetically related strain that is resistant
to accelerated senescence (25). We herein show that SAMP8
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mice display an accelerated depletion of the hippocampal NSC
pool compared with SAMR1 that coincides in space and time
with an increase in astroglial differentiation, a reduction in
neurogenesis, an increase in BMP6 protein level, and a dysre-
gulation of the BMP signaling pathway. We also demonstrate
that blocking the enhanced BMP signaling of the SAMP8 strain
restores normal NSC numbers by counteracting the BMP-
mediated NSC astroglial differentiation and simultaneously
ameliorates the neurogenic and behavioral deficits of the
senescent strain.
Results
SAMP8 Mice Show an Accelerated Depletion of the Adult Hippocampal
NSC Pool. We first measured the time course of stem cell decay in
the SGZ of mice with pathological aging (SAMP8) and age-
matched control animals with healthy aging (senescence
accelerated-resistant mice, SAMR1). We found a progressive
age-dependent decrease in SOX2+GFAP+ NSCs with radial
morphology in both strains; however, SAMP8 mice exhibited
lower radial NSC numbers compared with SAMR1 mice already
at the age of 2 mo (Fig. 1 A and E), evidencing the loss of the stem
cell population before the onset of AD symptoms (28–30). The
total number of SOX2+ cells (SI Appendix, Fig. S1) and SOX2+
GFAP− NR progenitors (Fig. 1B) was also lower in 2-mo SAMP8
vs. SAMR1. The proportion of NSCs and NR cells that stained for
the cell-cycle marker Ki67 was higher in SAMP8 (Fig. 1 C and D).
No statistically significant differences were found in the pro-
portion of NSCs that incorporated the thymidine analog BrdU
during S phase (2 h after BrdU injection, P = 0.24) and, conse-
quently, the BrdU/Ki67 ratio [which is inversely proportional to
cell-cycle length (32)] was lower in SAMP8 vs. SAMR1. In sum-
mary, the stem and progenitor cell pools become precociously
depleted in the hippocampus of the senescence model SAMP8 but
the remaining NSCs remain proliferative and apparently lengthen
their cell cycle.
The Newly Generated Hippocampal Cells Fail to Undergo Normal
Differentiation and Survival in SAMP8 Mice. To analyze the dy-
namics of neuronal production in 2-mo SAMP8 and SAMR1
animals, we employed a BrdU pulse-chase approach. BrdU in-
corporates into the newly synthesized DNA during cell division,
enabling the labeling of dividing cells at the time of injection and
their progenies after prolonged chase periods (33). We per-
formed a single injection (pulse) of BrdU and chased the analog
at 2 h, 1 d, and 3 d postpulse (Fig. 2A). The total number of
BrdU+ cells in the SGZ was similar between both strains at the
2-h and 1-d chase time points but decreased in SAMP8 animals
later on (Fig. 2B). The number of BrdU+ NSCs and BrdU+ NR
cells was similar for both strains and there were no differences in
their temporal dynamics, suggesting that the cells give rise to new
progeny at a similar pace (Fig. 2 C and D). When we examined
the DCX+ immature neuron compartment, we found equal
numbers of newly generated BrdU+DCX+ cells at 2 h and 1
d postpulse but a significant reduction at 3 d, pointing to a loss of
the newborn neurons as they progress toward maturation (Fig.
2E). In accordance with this finding, we detected a rise in the
number of active Caspase3+ apoptotic cells in SAMP8 mice (Fig.
2F). Concomitant with the loss of the newborn BrdU+DCX+
neurons, we found an abnormal accumulation of the DCX+ cell
population (Fig. 3 A and B). Not only was the total number of
DCX+ cells abnormally increased in SAMP8 animals but also
their location was altered (Fig. 3 A–C). In animals with patho-
logical aging, DCX+ cells migrated deeper into the granule cell
layer (GCL) and were aberrantly positioned. Moreover, the
number of DCX+ cells that acquired the more mature neuronal
marker calretinin (CR) was decreased (Fig. 3D). Overall, the
data suggest that the increase in cell death of the newly gener-
ated cells is accompanied by a failure to undergo a normal
neuronal differentiation program in the SAMP8 microenviron-
ment. To confirm whether this defect finally results in a re-
duction in the number of new granule neurons reaching maturity,
we injected another cohort of animals with BrdU and killed it 3
wk later. The number of newly generated NeuN+BrdU+ neurons
that had matured and integrated into the DG was signifi-
cantly reduced in the SAMP8 strain (Fig. 3E). Notably, con-
comitant with the decrease in neurogenesis at 2 mo, we also
detected a fourfold increase in the number of newly generated
S100b+BrdU+ astrocytes (Fig. 3F), suggesting that the loss of the
stem cell population in SAMP8 mice could be due to their prefer-
ential differentiation into mature astrocytic cells. This cellular out-
put is in accordance with previous findings in aged animals (10–13).
BMP6 Levels Are Elevated in the Hippocampal DG of SAMP8 Mice. The
signals that regulate the age-related depletion of the adult hip-
pocampal stem cells and their conversion to astroglia have not
yet been identified. Given the progliogenic role of BMPs at late
developmental stages (34), and since the expression of BMP





Fig. 1. NSCs and progenitor (NR) cells are precociously depleted in the
hippocampus of the SAMP8 model. (A and B) SAMP8 animals show a decreased
number of SOX2+GFAP+ radial NSC (A) and SOX2+GFAP−NR cells (B) compared
with 2-mo SAMR1 (*P < 0.05 and ***P < 0.001, respectively). Both strains show
an age-related reduction of these cell populations (SAMR1: ΔP < 0.05; SAMP8:
#P < 0.05, ##P < 0.01). (C and D) Two-month SAMP8 animals exhibit a higher
percentage of actively dividing Ki67+ radial NSCs (C) and NR cells (D) vs. SAMR1
(*P < 0.05). (E) Representative coronal micrograph showing the reduction of
the number of radial NSCs and NR cells in 2-mo SAMP8 strain vs. SAMR1. (Scale
bar, 100 μm.) (Magnification: E, Insets, 5×.)




















human hippocampus (19–24), we speculated that an early rise in
BMP ligands and BMP signaling could underlie the SAMP8
defects. We screened the gene expression of BMPs and BMP-
related signaling components in the SAMP8 and SAMR1 DG
tissue (Fig. 4A). We found a significant age-dependent increase
in Bmp4 and Bmp6 mRNAs in SAMP8 that peaked at the age of
2 mo (Fig. 4B) and was specific for the DG (SI Appendix, Fig.
S2). We selected these two genes to further analyze their ex-
pression at the protein level (Fig. 4 D and E). We also measured
the amount of P-SMAD1/5/8 relative to total SMAD1/5/8 as an
estimate of the canonical BMP signaling pathway activity (Fig. 4
D–F). We confirmed a significant threefold rise in the mature
BMP6 protein, but not in the mature BMP4 protein, as well as an
increase in canonical BMP signaling in the DG of 2-mo SAMP8
animals vs. age-matched SAMR1 animals. A similar rise in
BMP6 has been described in AD patients (22).
BMP6 Blocks the Expansion of Adult Hippocampal Stem and
Progenitor Cell Cultures by Promoting Astroglial Differentiation. To
directly evaluate the effect of BMP6 on adult hippocampal
neural stem and progenitor cells (NSPCs) we turned to an
in vitro assay. We isolated mouse primary NSPC cultures from
wild-type Crl:CD1 2-mo-old animals and expanded them with
mitogens in the presence or absence of 50 ng/mL BMP6. The
purity of the NSPC cultures was confirmed before the treatment
(SI Appendix, Fig. S3). As shown in Fig. 5A, BMP6 treatment
effectively induced canonical signaling in adult hippocampal
NSPCs. Despite the continuous mitogenic stimulation, BMP6
severely impaired the expansion of the cultures (Fig. 5B) and
promoted their differentiation into postmitotic GFAP+BrdU−
astroglial cells (Fig. 5 C and D). We did not observe signs of
increased apoptosis (TUNEL+ cells) or cellular senescence (SA-
b-gal+ cells) (SI Appendix, Fig. S4). To elucidate whether the
BMP6 effects are cell-autonomous or not, we analyzed BMP6
expression in NSPCs isolated from the DG of 2-mo SAMP8 and
SAMR1 animals (SI Appendix, Figs. S3 and S5). BMP6 mRNA
and preprotein levels were very low and the amount was reduced
in SAMP8 NSPCs compared with SAMR1 NSPCs (SI Appendix,
Fig. S5). BMP6 production in its mature functional form was
negligible in both cultures. Of note, we found that SAMP8
NSPCs expanded more slowly (n = 9, P < 0.01) and had a
decreased CldU/Ki67 ratio compared with SAMR1 NSPCs (79%
lower, n = 3, P < 0.05); no significant differences in apoptosis
were encountered (SI Appendix, Fig. S6). Treating the cells with
the BMP natural antagonist Noggin had no effect on the growth
of the cultures (SI Appendix, Fig. S7). Furthermore, SAMP8
NSPCs and SAMR1 NSPCs responded similarly to exogenously
added BMP6 ligand (SI Appendix, Fig. S8). Together, the in vitro
data suggest that the loss of the adult hippocampal stem cell
population in mice with accelerated aging could be due to a
noncell autonomous (niche) progliogenic effect of BMP6 ca-
nonical signaling. Moreover, NSPCs from SAMP8 mice display a
cell-cycle lengthening trend that seems rather an intrinsic feature
of the cells, in line with recent aging studies in the subependymal
zone niche (35).
Intracranial Infusion of the BMP Antagonist Noggin Rescues Hippocampal
Stem Cell Loss in SAMP8Mice and Ameliorates the Neurogenic Deficits.To
test whether increased BMP signaling plays a role in the stem cell
depletion and neurogenic defects in mice with pathological aging we
analyzed the impact of administering the antagonist Noggin. For this
purpose, we implanted osmotic minipumps in SAMP8 and SAMR1
animals and infused Noggin or saline solution as a control into the
brain. Mice were injected with BrdU on the last day of infusion and
were either killed 3 d (Fig. 6) or 3 wk later (Fig. 7). As shown in Fig.
6, Noggin efficiently rescued the precocious loss of hippocampal
radial NSCs in SAMP8 (Fig. 6 B–E). The total number of stem cells
increased almost twofold in SAMP8 animals and reached the values
of the SAMR1 strain. As previously reported by our group (18),
Noggin did not change the total number of radial NSCs in control
animals (Fig. 6B), although it increased their cycling activity (Fig. 6 C
and D), suggesting that under normal healthy conditions Noggin
enhances the asymmetric division of NSCs. In contrast, although
Noggin augmented the total number of radial NSCs in SAMP8 an-
imals, it did not further increase their cell cycle, pointing to a specific
A B E
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Fig. 2. Newborn neurons are lost in 2-mo SAMP8 animals. (A) Pulse-chase
experimental design using BrdU. Animals were killed at 2 h (2h), 1 d (1d) and
3 d (3d) after BrdU injection. (B) BrdU+ cells at the chase time points after
injection. SAMP8 animals show a reduction at 3 d vs. SAMR1 (*P < 0.05).
SAMR1 animals show an increase over time (##P < 0.01). (C and D) BrdU+
radial NSCs (C) and BrdU+ NR progenitors (D) at different chase time points.
Neither radial NSCs nor NR cells show differences in temporal dynamics. (E)
BrdU+DCX+ newborn neurons at all chase time points. SAMP8 strain shows a
reduction in this population at 3 d compared with SAMR1. (F) Active Casp3+
cells at 3 d after BrdU injection, showing an increase in cell death in the DG
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Fig. 3. Newborn neurons of 2-mo SAMP8 animals fail to undergo proper
maturation. (A) Representative images of the altered number and location of
DCX+ cells in 2-mo SAMP8 vs. SAMR1. Arrows indicate DCX+ cells with altered
location in SAMP8 GCL. (Scale bar, 25 μm.) (B and C) Number of DCX+ cells (B)
and analysis of their location (C). In control animals, DCX+ cells were mainly
confined to the innermost (first) third of the DG. SAMP8 animals showed an
increased number and abnormal location of this cell population. (D) Number of
DCX+CR+ cells at 2 mo, showing a decrease in SAMP8. (E and F) Number of
NeuN+BrdU+mature neurons (E) and S100β+BrdU+mature astrocytes (F) 3 wk
after BrdU injection. SAMP8 animals generate fewer mature neurons and more
mature astrocytes. (Right) Image showing a SAMP8 S100β+BrdU+ mature as-
trocyte, as an example. (Scale bar, 10 μm.) *P < 0.05, **P < 0.01.



























effect of Noggin exposure in animals with pathological aging, which
are endowed with higher DG levels of BMP6 and BMP signaling
compared with control mice. We next explored whether Noggin
administration rescued the progliogenic phenotype of the SAMP8
animals and/or ameliorated the neurogenic defects. Noggin infusion
diminished the differentiation of the NSC pool toward the astrocytic
lineage and increased the production of fully mature neurons (Fig.
7A). It also significantly reduced the aberrant accumulation and ec-
topic location of the immature DCX+ cells (SI Appendix, Fig. S9).
Together, the data suggest that blocking the enhanced BMP signaling
of the SAMP8 strain restores normal hippocampal NSC numbers,
most likely by counteracting the BMP-mediated astroglial differen-
tiation, and simultaneously improves the neurogenic defects of the
senescent strain.
Behavioral Deficits in SAMP8 Mice Are Rescued by Noggin. SAMP8
mice show age-associated behavioral impairments at 6 mo, such
as learning and memory deficits (36) and reduced anxiety (37),
so next we analyzed the behavioral phenotype of both SAMR1
and SAMP8 6-mo animals infused with Noggin or saline (Fig.
7B). We found that SAMP8 animals spent significantly longer
times at the open arms of the elevated plus maze compared with
SAMR1 mice, pointing to clear differences in anxiety (Fig. 7C).
Interestingly, Noggin normalized the anxiety behavior of SAMP8
animals to the levels of SAMR1 animals (Fig. 7C). To test their
learning and memory capabilities, SAMR1 and SAMP8 5-mo
animals were injected with a lentivirus (LV) overexpressing
Noggin or GFP as a control and their performance in the Morris
water maze test was evaluated (Fig. 7D). Noggin improved the
acquisition phase of the test in SAMP8 animals; learning of the
LV-Noggin-SAMP8 group was superior to that of LV-GFP-
SAMP8 group across a number of days of testing (Fig. 7E). A
clear effect was also found when the animals were tested in the
probe trial to analyze the quality of the learning process or short-
term memory retention (Fig. 7F and SI Appendix, Fig. S10). SAMP8
mice obtained a lower score, pointing to worse learning. This dif-
ference was fully restored by Noggin in SAMP8 animals, which spent
similar times in the platform quadrant compared with SAMR1 mice.
Discussion
Age-related neurodegenerative disorders such as AD slowly
undermine cognitive function and behavioral abilities. Although
AD is not a part of normal healthy aging, the rate of the disease
doubles every decade after the age of 60. Alterations in hippo-
campal neurogenesis, which have been extensively documented
both during normal aging and in AD (7–9), possibly contribute to
the age- and AD-related hippocampal dysfunction, but the mech-
anistic causes underlying this phenomenon remain poorly un-
derstood. Hence, unraveling the changes affecting the hippocampal
neurogenic niche and the hippocampal stem cell dynamics during
aging and, most importantly, at early presymptomatic AD stages,
may provide new insights into the progression of the disease.
We herein show that BMP6 accumulates very early in the
hippocampal niche of SAMP8 animals, a senescent strain that
has been used to model some age-related aspects of the onset of
sporadic AD. BMP6 is also significantly increased at the mRNA
and protein levels in the hippocampus of patients with early and
severe AD compared with nondemented controls and in a
transgenic mouse model of familial AD (22). BMP6 accumulates
around Aβ plaques in the hippocampus and, as in SAMP8, the
accumulation in human tissue is accompanied by reduced hip-
pocampal neurogenesis and SOX2+ cells. Moreover, at least





Fig. 5. BMP6 promotes astroglial differentiation of cultured adult hippo-
campal NSPCs. (A) Canonical signaling activation in cultured NSPCs after
BMP6 treatment. (B) In vitro cell growth kinetics at 0, 4, 7, and 10 d (DIV).
BMP6 impaired the expansion of NSPC cultures (*P < 0.05, ***P < 0.001). (C)
Postmitotic astroglial differentiation (GFAP+BrdU−) of primary NSPC cul-
tures after BMP6 treatment. (D) Percentage of GFAP+ and BrdU+ cells after
BMP6 treatment. BMP6 impairs proliferation (0% BrdU+, **P < 0.01) and
induces astroglial differentiation (% GFAP+, **P < 0.01). Data correspond to






Fig. 4. BMP6 levels are increased in the DG of SAMP8 mice. (A) Heat map
showing the mRNA levels (a.u.) of BMP-related signaling components in the DG
of 2-mo, 6-mo, and 10-mo SAMR1 and SAMP8. (B) Bmp4 and (C) Bmp6 mRNA
expression is significantly increased in 2-mo SAMP8 vs. SAMR1. (D–F) Western
blot and densitometry analysis of 2-mo DG lysates (D) showing an increased
content in BMP6 normalized to β-actin (E) and P-SMAD1/5/8 normalized to total
SMAD1/5/8 (F) in 2-mo SAMP8 vs. SAMR1. *P < 0.05, **P < 0.01, ##P < 0.01.




















BMP6 (22). An increase in BMP6 has been also reported during
healthy aging in wild-type mice, possibly associated to microglial
cells, the resident immune cells of the brain (23). Thus, although
the available data suggest that BMP6 accumulates during healthy
aging, the process may be exacerbated in pathological conditions
such as AD that lead to increased Aβ levels, the activation of
microglia, and an unfavorable inflammatory microenvironment
(38, 39). Increased Aβ levels and inflammation have been de-
tected in the SAMP8 brain (40–42) and could therefore con-
tribute to the rise of BMP6 in this mouse model.
Our results indicate that the increase in BMP6 and in ca-
nonical BMP signaling mainly results in the precocious depletion
of the adult hippocampal NSCs due to their BMP-mediated
differentiation into astroglial cells. Interestingly, in 2-mo SAMP8
mice the remaining hippocampal NSCs proliferate and continue
to generate new immature neurons, but these cells have a re-
duced survival and display an aberrant delay in differentiation,
leading to a reduction in the number of NeuN+ granule neurons
reaching maturity, as reported elsewhere (43). A similar aberrant
hindrance to the normal development of the immature neuronal
population has been described in the aging brain of wild-type mice
(6), in the brain of AD patients, and in some transgenic AD models
of the familial early-onset forms of the disease (7–9, 22, 44).
Increasing evidence suggests that the aged and AD neurogenic
niche is no longer optimal for neurogenesis (7–9); however, taking
advantage of the SAMP8model and employing the BMP antagonist
Noggin we demonstrate that it is still possible to influence the niche
microenvironment, to rescue stem cell numbers, and to revert the
pathological neurogenic phenotype by means of blocking the ab-
errant BMP signaling. The treatment with Noggin also normalized
the behavioral phenotype of SAMP8 animals, making the scores
similar to those of control SAMR1 animals. The SAMP8 anxiety
phenotype, the spatial learning defects, and the short-term memory
retention capacity were improved by Noggin. In line with our re-
sults, hippocampal neurogenesis has been also rescued in transgenic
AD models with Noggin (20) and it has been shown that increased
BMP signaling results in cognitive impairments, while its reduction
ameliorates hippocampus-dependent cognitive function in young
and aged mice (24, 45, 46).
In summary, age-related stem cell depletion and dysfunction may
result from a combination of several factors, both intrinsic and ex-
trinsic to the stem cell compartment, that are dysregulated with
increasing age and that may be exacerbated in pathological condi-
tions such as AD. Our data show that the temporal increase of
BMP6 expression in the DG may be one of such altered extrinsic
factors. The cell cycle lengthening of NSPCs may be rather a cell
intrinsic feature (35). The loss of the stem cell population in
SAMP8 mice is due to their differentiation into mature astrocytic




Fig. 7. Noggin infusion counteracts the NSC astroglial differentiation and
the neurogenic and behavioral defects in SAMP8. (A) Percentage of S100β+
BrdU+ mature astrocytes (Left) and NeuN+BrdU+ mature neurons (Right)
after treating 2-mo SAMP8 with saline or Noggin (7-d infusion as in Fig. 6A)
at 21 d after BrdU injection. SAMP8 show an increased number of mature
neurons at the expense of mature astrocytes (*P < 0.05). (B) Experimental
design for the Noggin 28-d infusion employing minipums and elevated plus
maze (EPM). (C) Total time spent in the open and closed arms of the ele-
vated plus maze. Noggin restored SAMP8 anxiety behavior to control levels
(*P < 0.05, **P < 0.01). (D–F) Experimental design for the Morris water maze
(MWM). (D) Experimental design of the lentiviral injection and MWM. Rel-
ative Noggin mRNA expression by RT-qPCR is also shown in fold (a.u.) (*P <
0.01). (E) Learning curve calculated as daily mean escape latency during five
consecutive days (*P < 0.05; LV-Noggin-SAMP8 vs. LV-GFP-SAMP8). A ha-
bituation trial (60 s without platform was performed on day 0; see SI Ap-
pendix, SI Materials and Methods). (F) Probe trial showing the absolute time







Fig. 6. Intracranial infused Noggin rescues hippocampal NSC loss in SAMP8. (A)
Minipump infusion and pulse-chase experimental design using Noggin and BrdU.
Two-month animals were infused with Noggin for 7 d and injected with BrdU
the last day of infusion. Animals were killed 3 d after BrdU injection (21 d for Fig.
7A). (B) SAMP8 animals show an increase in the number of radial NSCs when
treated with Noggin compared with control saline-treated animals (##P < 0.01).
(C and D) The number of proliferating Ki67+ radial NSCs is increased in SAMP8
animals treated with Noggin (C, #P < 0.05). The percentage of proliferating radial
NSCs is restored to SAMR1 levels (D, *P < 0.05). (E) Representative images
showing the increase in radial NSCs after intracranial Noggin infusion in 2-mo
SAMP8 animals. (Scale bar, 100 μm.) (Magnification: E, Insets, 5×.)



























(19–24). We have uncovered why this defective fate choice occurs
and how we might mitigate it by manipulating the stem cell niche.
The increased glial differentiation of the NSCs can further help to
explain the hippocampal astrocytosis that is detected in the SAMP8
strain starting at 6 mo of age (26) and that characterizes the late
stages of AD (47). Our findings, combined with previous reports in
which the in vivo delivery of lentiviral shRNA against downstream
effectors of the BMP pathway partially rejuvenated NSC function in
the aged brain (23, 24), support further development of BMP an-
tagonists into translatable molecules for the rescue of stem cell
depletion and neurogenesis during healthy and pathological aging.
Materials and Methods
Animals. SAMP8 and SAMR1 males were used at 1, 2, 6, and 10 mo. Crl:CD1
males were used at 2 mo (SI Appendix). Mice were maintained under specific-
pathogen-free conditions and all manipulations were approved by the An-
imal Care Committee of the Instituto de Salud Carlos III.
Immunostaining.Antibody stainingswere performed as described in SI Appendix.
DGNSPC Culture.NSPCswere isolated fromdissected hippocampi of 2-mo-old Crl:
CD1, SAMR1, and SAMP8 mice and cultured in FGF2 and EGF (SI Appendix).
Intracerebroventricular Infusion. Alzet osmotic minipumps were implanted in
SAMR1 and SAMP8 mice for Noggin or vehicle solution infusion. Different
experimental paradigms of infusion and BrdU administrationwere applied (SI
Appendix).
Lentiviral Injections. Five-month-old SAMP8 and SAMR1 males underwent
stereotaxic surgery, and a 1.5-μL suspension of lentiviral ORF particles
expressing Noggin or GFP (Origene Technologies) was injected into both
hemispheres at DG coordinates (SI Appendix).
Behavioral Assessments. Animals’ general activity was tested with a Versa-
Max Animal Activity Monitoring System. For anxiety measurement and
spatial learning and memory tests, elevated plus maze and Morris water
maze were performed as described in SI Appendix.
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